What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Gland Pharma Limited IPO?

Based on the upper price band of ₹1500 and current GMP of ₹118, the estimated listing price is ₹1618 (approx. 7.9% gain).

What is the expected profit per lot for Gland Pharma Limited IPO?

With a lot size of 10 shares and current GMP of ₹118, expected profit per retail application lot is approximately ₹1,180.

IPO GreyPremiumLIVE

Grey Market Intelligence

Gland Pharma Limited

ListedSME

Healthcare / Pharmaceuticals & Biotechnology · NSE / BSE

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

Price Band

₹1490 – ₹1500

Issue Size

₹6480 Cr

Lot Size

10 shares

GMP

₹118

+7.9%

Est. Listing

₹1618

at current GMP

Subscribed

—

Open

9 Nov 2020

11 Nov 2020

Allotment

18 Nov 2020

Refund

19 Nov 2020

Demat Credit

20 Nov 2020

Listing

20 Nov 2020

Last updated 10 months ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Gland Pharma Limited GMP Today

Last updated: 22 Dec 2025

Current Premium

₹118+7.9%

Issue Price (Upper)

₹1500

Band: ₹1490 – ₹1500

Estimated Listing Price

₹1618

Upper price + GMP

Lot Size

10 shares

Min investment ₹15,000

Estimated Profit / Lot

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹118	7.9%	₹1618
30 Oct 2026	+₹118	7.9%	₹1618
29 Oct 2026	+₹106	7.1%	₹1606

About Gland Pharma Limited Public Issue & Market Profile

Gland Pharma Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals & Biotechnology sector with an aggregate issue size of ₹6,479.55 Crores. The shares are offered at a price band of ₹1490 to ₹1500 per equity share on NSE and BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.

Public Issue & Pricing Context:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 10 shares (approx. ₹15,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Basis of Allotment & Listing Timeline:

Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2020-11-20, while un-allotted funds or UPI block mandates will be released on 2020-11-19.

Frequently Asked Questions

What is Gland Pharma Limited IPO GMP today?

The latest grey market premium for Gland Pharma Limited IPO is ₹118, which indicates an expected listing price of ₹1618.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.